デフォルト表紙
市場調査レポート
商品コード
1067646

幹細胞の世界市場 - 考察・予測 (2028年まで)

Global Stem Cells Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 125 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=137.14円
幹細胞の世界市場 - 考察・予測 (2028年まで)
出版日: 2022年03月31日
発行: QYResearch
ページ情報: 英文 125 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の幹細胞の市場規模は、2021年の27億5,300万米ドルから、2028年までに57億2,720万米ドルに達し、2022年~2028年の間にCAGRで10.9%の成長が予測されています。

当レポートでは、世界の幹細胞市場について調査分析し、セグメント別の市場分析、収益・予測 (2017年~2028年) に焦点を当てて、最新の情報を提供しています。

目次

第1章 レポートの事業概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の幹細胞の市場規模の成長率:タイプ別
    • 幹細胞の保管
    • 幹細胞の医薬品・治療
  • 市場:適応別
    • 世界の幹細胞の市場規模の成長率:適応別
    • 血液疾患
    • がん
    • 自己免疫疾患
    • その他
  • 調査目的
  • 対象年

第2章 世界の成長動向

  • 世界の幹細胞市場の見通し
  • 幹細胞の成長動向:地域別
  • 幹細胞の市場力学
    • 幹細胞の業界動向
    • 幹細胞の市場促進要因
    • 幹細胞の市場課題
    • 幹細胞の市場抑制要因

第3章 競合情勢:主要企業別

  • 世界の幹細胞の主要企業:収益別
  • 世界の幹細胞の市場シェア:企業タイプ別(ティア1、ティア2、ティア3)
  • 対象企業 - ランキング:幹細胞の収益別
  • 世界の幹細胞の市場集中度
  • 幹細胞の主要企業の本社と提供エリア
  • 幹細胞の主要企業の製品ソリューションとサービス
  • 幹細胞の市場参入日
  • M&A、拡張計画

第4章 幹細胞の内訳データ:タイプ別

  • 世界の幹細胞の過去の市場規模:タイプ別
  • 世界の幹細胞の市場規模予測:タイプ別

第5章 幹細胞の内訳データ:適応別

  • 世界の幹細胞の過去の市場規模:適応別
  • 世界の幹細胞の市場規模予測:適応別

第6章 北米

  • 北米の幹細胞の市場規模
  • 北米の幹細胞の市場規模:タイプ別
  • 北米の幹細胞の市場規模:適応別
  • 北米の幹細胞の市場規模:国別
    • 米国
    • カナダ

第7章 欧州

  • 欧州の幹細胞の市場規模
  • 欧州の幹細胞の市場規模:タイプ別
  • 欧州の幹細胞の市場規模:適応別
  • 欧州の幹細胞の市場規模:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧諸国

第8章 アジア太平洋地域

  • アジア太平洋地域の幹細胞の市場規模
  • アジア太平洋地域の幹細胞の市場規模:タイプ別
  • アジア太平洋地域の幹細胞の市場規模:適応別
  • アジア太平洋地域の幹細胞の市場規模:地域別
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの幹細胞の市場規模
  • ラテンアメリカの幹細胞の市場規模:タイプ別
  • ラテンアメリカの幹細胞の市場規模:適応別
  • ラテンアメリカの幹細胞の市場規模:国別
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの幹細胞の市場規模
  • 中東・アフリカの幹細胞の市場規模:タイプ別
  • 中東・アフリカの幹細胞の市場規模:適応別
  • 中東・アフリカの幹細胞の市場規模:国別
    • トルコ
    • サウジアラビア
    • アラブ首長国連邦

第11章 主要企業のプロファイル

  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • Medi-post
  • JCR Pharmaceutical
  • MolMed
  • Pharmicell
  • Anterogen
  • Takeda (TiGenix)
  • CBR
  • ViaCord
  • Esperite
  • LifeCell
  • CCBC
  • VCANBIO
  • BOYA LIFE
  • Beike Biotechnology
  • International Medical
  • Global Cord Blood Corporation
  • Beijing Health-Biotech Group
  • ABMD

第12章 アナリストの視点/結論

第13章 付録

図表

LIST OF TABLES

List of Tables

  • Table 1. Global Stem Cells Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Stem Cell Storage
  • Table 3. Key Players of Stem Cell Pharmaceutical and Treatment
  • Table 4. Global Stem Cells Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Stem Cells Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Stem Cells Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Stem Cells Market Share by Region (2017-2022)
  • Table 8. Global Stem Cells Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Stem Cells Market Share by Region (2023-2028)
  • Table 10. Stem Cells Market Trends
  • Table 11. Stem Cells Market Drivers
  • Table 12. Stem Cells Market Challenges
  • Table 13. Stem Cells Market Restraints
  • Table 14. Global Stem Cells Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Stem Cells Revenue Share by Players (2017-2022)
  • Table 16. Global Top Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2021)
  • Table 17. Ranking of Global Top Stem Cells Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Stem Cells Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Stem Cells Product Solution and Service
  • Table 21. Date of Enter into Stem Cells Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Stem Cells Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Stem Cells Revenue Market Share by Type (2017-2022)
  • Table 25. Global Stem Cells Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Stem Cells Revenue Market Share by Type (2023-2028)
  • Table 27. Global Stem Cells Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Stem Cells Revenue Share by Application (2017-2022)
  • Table 29. Global Stem Cells Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Stem Cells Revenue Share by Application (2023-2028)
  • Table 31. North America Stem Cells Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Stem Cells Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Stem Cells Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Stem Cells Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Stem Cells Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Stem Cells Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Stem Cells Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Stem Cells Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Stem Cells Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Stem Cells Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Stem Cells Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Stem Cells Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Stem Cells Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Stem Cells Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Stem Cells Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Stem Cells Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Stem Cells Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Stem Cells Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Stem Cells Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Stem Cells Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Stem Cells Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Stem Cells Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Stem Cells Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Stem Cells Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Stem Cells Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Stem Cells Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Stem Cells Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Stem Cells Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Stem Cells Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Stem Cells Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. Osiris Therapeutics Company Details
  • Table 62. Osiris Therapeutics Business Overview
  • Table 63. Osiris Therapeutics Stem Cells Product
  • Table 64. Osiris Therapeutics Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 65. Osiris Therapeutics Recent Developments
  • Table 66. NuVasive Company Details
  • Table 67. NuVasive Business Overview
  • Table 68. NuVasive Stem Cells Product
  • Table 69. NuVasive Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 70. NuVasive Recent Developments
  • Table 71. Chiesi Pharmaceuticals Company Details
  • Table 72. Chiesi Pharmaceuticals Business Overview
  • Table 73. Chiesi Pharmaceuticals Stem Cells Product
  • Table 74. Chiesi Pharmaceuticals Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 75. Chiesi Pharmaceuticals Recent Developments
  • Table 76. Medi-post Company Details
  • Table 77. Medi-post Business Overview
  • Table 78. Medi-post Stem Cells Product
  • Table 79. Medi-post Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 80. Medi-post Recent Developments
  • Table 81. JCR Pharmaceutical Company Details
  • Table 82. JCR Pharmaceutical Business Overview
  • Table 83. JCR Pharmaceutical Stem Cells Product
  • Table 84. JCR Pharmaceutical Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 85. JCR Pharmaceutical Recent Developments
  • Table 86. MolMed Company Details
  • Table 87. MolMed Business Overview
  • Table 88. MolMed Stem Cells Product
  • Table 89. MolMed Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 90. MolMed Recent Developments
  • Table 91. Pharmicell Company Details
  • Table 92. Pharmicell Business Overview
  • Table 93. Pharmicell Stem Cells Product
  • Table 94. Pharmicell Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 95. Pharmicell Recent Developments
  • Table 96. Anterogen Company Details
  • Table 97. Anterogen Business Overview
  • Table 98. Anterogen Stem Cells Product
  • Table 99. Anterogen Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 100. Anterogen Recent Developments
  • Table 101. Takeda (TiGenix) Company Details
  • Table 102. Takeda (TiGenix) Business Overview
  • Table 103. Takeda (TiGenix) Stem Cells Product
  • Table 104. Takeda (TiGenix) Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 105. Takeda (TiGenix) Recent Developments
  • Table 106. CBR Company Details
  • Table 107. CBR Business Overview
  • Table 108. CBR Stem Cells Product
  • Table 109. CBR Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 110. CBR Recent Developments
  • Table 111. ViaCord Company Details
  • Table 112. ViaCord Business Overview
  • Table 113. ViaCord Stem Cells Product
  • Table 114. ViaCord Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 115. ViaCord Recent Developments
  • Table 116. Esperite Company Details
  • Table 117. Esperite Business Overview
  • Table 118. Esperite Stem Cells Product
  • Table 119. Esperite Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 120. Esperite Recent Developments
  • Table 121. LifeCell Company Details
  • Table 122. LifeCell Business Overview
  • Table 123. LifeCell Stem Cells Product
  • Table 124. LifeCell Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 125. LifeCell Recent Developments
  • Table 126. CCBC Company Details
  • Table 127. CCBC Business Overview
  • Table 128. CCBC Stem Cells Product
  • Table 129. CCBC Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 130. CCBC Recent Developments
  • Table 131. VCANBIO Company Details
  • Table 132. VCANBIO Business Overview
  • Table 133. VCANBIO Stem Cells Product
  • Table 134. VCANBIO Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 135. VCANBIO Recent Developments
  • Table 136. BOYA LIFE Company Details
  • Table 137. BOYA LIFE Business Overview
  • Table 138. BOYA LIFE Stem Cells Product
  • Table 139. BOYA LIFE Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 140. BOYA LIFE Recent Developments
  • Table 141. Beike Biotechnology Company Details
  • Table 142. Beike Biotechnology Business Overview
  • Table 143. Beike Biotechnology Stem Cells Product
  • Table 144. Beike Biotechnology Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 145. Beike Biotechnology Recent Developments
  • Table 146. International Medical Company Details
  • Table 147. International Medical Business Overview
  • Table 148. International Medical Stem Cells Product
  • Table 149. International Medical Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 150. International Medical Recent Developments
  • Table 151. Global Cord Blood Corporation Company Details
  • Table 152. Global Cord Blood Corporation Business Overview
  • Table 153. Global Cord Blood Corporation Stem Cells Product
  • Table 154. Global Cord Blood Corporation Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 155. Global Cord Blood Corporation Recent Developments
  • Table 156. Beijing Health-Biotech Group Company Details
  • Table 157. Beijing Health-Biotech Group Business Overview
  • Table 158. Beijing Health-Biotech Group Stem Cells Product
  • Table 159. Beijing Health-Biotech Group Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 160. Beijing Health-Biotech Group Recent Developments
  • Table 161. ABMD Company Details
  • Table 162. ABMD Business Overview
  • Table 163. ABMD Stem Cells Product
  • Table 164. ABMD Revenue in Stem Cells Business (2017-2022) & (US$ Million)
  • Table 165. ABMD Recent Developments
  • Table 166. Research Programs/Design for This Report
  • Table 167. Key Data Information from Secondary Sources
  • Table 168. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Stem Cells Market Share by Type: 2021 VS 2028
  • Figure 2. Stem Cell Storage Features
  • Figure 3. Stem Cell Pharmaceutical and Treatment Features
  • Figure 4. Global Stem Cells Market Share by Application: 2021 VS 2028
  • Figure 5. Blood Disease Case Studies
  • Figure 6. Cancer Case Studies
  • Figure 7. Autoimmune Disease Case Studies
  • Figure 8. Others Case Studies
  • Figure 9. Stem Cells Report Years Considered
  • Figure 10. Global Stem Cells Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Stem Cells Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Stem Cells Market Share by Region: 2021 VS 2028
  • Figure 13. Global Stem Cells Market Share by Players in 2021
  • Figure 14. Global Top Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Stem Cells Revenue in 2021
  • Figure 16. North America Stem Cells Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Stem Cells Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Stem Cells Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Stem Cells Market Size Share by Country (2017-2028)
  • Figure 20. United States Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Stem Cells Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Stem Cells Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Stem Cells Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Stem Cells Market Size Share by Country (2017-2028)
  • Figure 26. Germany Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Stem Cells Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Stem Cells Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Stem Cells Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Stem Cells Market Size Share by Region (2017-2028)
  • Figure 36. China Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Stem Cells Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Stem Cells Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Stem Cells Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Stem Cells Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Stem Cells Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Stem Cells Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Stem Cells Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Stem Cells Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Stem Cells Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 56. NuVasive Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 57. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 58. Medi-post Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 59. JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 60. MolMed Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 61. Pharmicell Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 62. Anterogen Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 63. Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 64. CBR Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 65. ViaCord Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 66. Esperite Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 67. LifeCell Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 68. CCBC Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 69. VCANBIO Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 70. BOYA LIFE Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 71. Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 72. International Medical Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 73. Global Cord Blood Corporation Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 74. Beijing Health-Biotech Group Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 75. ABMD Revenue Growth Rate in Stem Cells Business (2017-2022)
  • Figure 76. Bottom-up and Top-down Approaches for This Report
  • Figure 77. Data Triangulation
  • Figure 78. Key Executives Interviewed
目次

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).

Market Analysis and Insights: Global Stem Cells Market

The global Stem Cells market size is projected to reach US$ 5727.2 million by 2028, from US$ 2753 million in 2021, at a CAGR of 10.9% during 2022-2028.

Stem cell industry of the world's major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stem Cells market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stem Cells market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stem Cells market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stem Cells market.

Global Stem Cells Scope and Market Size

Stem Cells market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Stem Cell Storage
  • Stem Cell Pharmaceutical and Treatment

Segment by Application

  • Blood Disease
  • Cancer
  • Autoimmune Disease
  • Others

By Company

  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • Medi-post
  • JCR Pharmaceutical
  • MolMed
  • Pharmicell
  • Anterogen
  • Takeda (TiGenix)
  • CBR
  • ViaCord
  • Esperite
  • LifeCell
  • CCBC
  • VCANBIO
  • BOYA LIFE
  • Beike Biotechnology
  • International Medical
  • Global Cord Blood Corporation
  • Beijing Health-Biotech Group
  • ABMD

By Region

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Stem Cells Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Stem Cell Storage
    • 1.2.3 Stem Cell Pharmaceutical and Treatment
  • 1.3 Market by Application
    • 1.3.1 Global Stem Cells Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Blood Disease
    • 1.3.3 Cancer
    • 1.3.4 Autoimmune Disease
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Stem Cells Market Perspective (2017-2028)
  • 2.2 Stem Cells Growth Trends by Region
    • 2.2.1 Stem Cells Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Stem Cells Historic Market Size by Region (2017-2022)
    • 2.2.3 Stem Cells Forecasted Market Size by Region (2023-2028)
  • 2.3 Stem Cells Market Dynamics
    • 2.3.1 Stem Cells Industry Trends
    • 2.3.2 Stem Cells Market Drivers
    • 2.3.3 Stem Cells Market Challenges
    • 2.3.4 Stem Cells Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Stem Cells Players by Revenue
    • 3.1.1 Global Top Stem Cells Players by Revenue (2017-2022)
    • 3.1.2 Global Stem Cells Revenue Market Share by Players (2017-2022)
  • 3.2 Global Stem Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Stem Cells Revenue
  • 3.4 Global Stem Cells Market Concentration Ratio
    • 3.4.1 Global Stem Cells Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Stem Cells Revenue in 2021
  • 3.5 Stem Cells Key Players Head office and Area Served
  • 3.6 Key Players Stem Cells Product Solution and Service
  • 3.7 Date of Enter into Stem Cells Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Stem Cells Breakdown Data by Type

  • 4.1 Global Stem Cells Historic Market Size by Type (2017-2022)
  • 4.2 Global Stem Cells Forecasted Market Size by Type (2023-2028)

5 Stem Cells Breakdown Data by Application

  • 5.1 Global Stem Cells Historic Market Size by Application (2017-2022)
  • 5.2 Global Stem Cells Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Stem Cells Market Size (2017-2028)
  • 6.2 North America Stem Cells Market Size by Type
    • 6.2.1 North America Stem Cells Market Size by Type (2017-2022)
    • 6.2.2 North America Stem Cells Market Size by Type (2023-2028)
    • 6.2.3 North America Stem Cells Market Share by Type (2017-2028)
  • 6.3 North America Stem Cells Market Size by Application
    • 6.3.1 North America Stem Cells Market Size by Application (2017-2022)
    • 6.3.2 North America Stem Cells Market Size by Application (2023-2028)
    • 6.3.3 North America Stem Cells Market Share by Application (2017-2028)
  • 6.4 North America Stem Cells Market Size by Country
    • 6.4.1 North America Stem Cells Market Size by Country (2017-2022)
    • 6.4.2 North America Stem Cells Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Stem Cells Market Size (2017-2028)
  • 7.2 Europe Stem Cells Market Size by Type
    • 7.2.1 Europe Stem Cells Market Size by Type (2017-2022)
    • 7.2.2 Europe Stem Cells Market Size by Type (2023-2028)
    • 7.2.3 Europe Stem Cells Market Share by Type (2017-2028)
  • 7.3 Europe Stem Cells Market Size by Application
    • 7.3.1 Europe Stem Cells Market Size by Application (2017-2022)
    • 7.3.2 Europe Stem Cells Market Size by Application (2023-2028)
    • 7.3.3 Europe Stem Cells Market Share by Application (2017-2028)
  • 7.4 Europe Stem Cells Market Size by Country
    • 7.4.1 Europe Stem Cells Market Size by Country (2017-2022)
    • 7.4.2 Europe Stem Cells Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Stem Cells Market Size (2017-2028)
  • 8.2 Asia-Pacific Stem Cells Market Size by Type
    • 8.2.1 Asia-Pacific Stem Cells Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Stem Cells Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Stem Cells Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Stem Cells Market Size by Application
    • 8.3.1 Asia-Pacific Stem Cells Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Stem Cells Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Stem Cells Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Stem Cells Market Size by Region
    • 8.4.1 Asia-Pacific Stem Cells Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Stem Cells Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Stem Cells Market Size (2017-2028)
  • 9.2 Latin America Stem Cells Market Size by Type
    • 9.2.1 Latin America Stem Cells Market Size by Type (2017-2022)
    • 9.2.2 Latin America Stem Cells Market Size by Type (2023-2028)
    • 9.2.3 Latin America Stem Cells Market Share by Type (2017-2028)
  • 9.3 Latin America Stem Cells Market Size by Application
    • 9.3.1 Latin America Stem Cells Market Size by Application (2017-2022)
    • 9.3.2 Latin America Stem Cells Market Size by Application (2023-2028)
    • 9.3.3 Latin America Stem Cells Market Share by Application (2017-2028)
  • 9.4 Latin America Stem Cells Market Size by Country
    • 9.4.1 Latin America Stem Cells Market Size by Country (2017-2022)
    • 9.4.2 Latin America Stem Cells Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Stem Cells Market Size (2017-2028)
  • 10.2 Middle East & Africa Stem Cells Market Size by Type
    • 10.2.1 Middle East & Africa Stem Cells Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Stem Cells Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Stem Cells Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Stem Cells Market Size by Application
    • 10.3.1 Middle East & Africa Stem Cells Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Stem Cells Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Stem Cells Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Stem Cells Market Size by Country
    • 10.4.1 Middle East & Africa Stem Cells Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Stem Cells Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Osiris Therapeutics
    • 11.1.1 Osiris Therapeutics Company Details
    • 11.1.2 Osiris Therapeutics Business Overview
    • 11.1.3 Osiris Therapeutics Stem Cells Introduction
    • 11.1.4 Osiris Therapeutics Revenue in Stem Cells Business (2017-2022)
    • 11.1.5 Osiris Therapeutics Recent Developments
  • 11.2 NuVasive
    • 11.2.1 NuVasive Company Details
    • 11.2.2 NuVasive Business Overview
    • 11.2.3 NuVasive Stem Cells Introduction
    • 11.2.4 NuVasive Revenue in Stem Cells Business (2017-2022)
    • 11.2.5 NuVasive Recent Developments
  • 11.3 Chiesi Pharmaceuticals
    • 11.3.1 Chiesi Pharmaceuticals Company Details
    • 11.3.2 Chiesi Pharmaceuticals Business Overview
    • 11.3.3 Chiesi Pharmaceuticals Stem Cells Introduction
    • 11.3.4 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2017-2022)
    • 11.3.5 Chiesi Pharmaceuticals Recent Developments
  • 11.4 Medi-post
    • 11.4.1 Medi-post Company Details
    • 11.4.2 Medi-post Business Overview
    • 11.4.3 Medi-post Stem Cells Introduction
    • 11.4.4 Medi-post Revenue in Stem Cells Business (2017-2022)
    • 11.4.5 Medi-post Recent Developments
  • 11.5 JCR Pharmaceutical
    • 11.5.1 JCR Pharmaceutical Company Details
    • 11.5.2 JCR Pharmaceutical Business Overview
    • 11.5.3 JCR Pharmaceutical Stem Cells Introduction
    • 11.5.4 JCR Pharmaceutical Revenue in Stem Cells Business (2017-2022)
    • 11.5.5 JCR Pharmaceutical Recent Developments
  • 11.6 MolMed
    • 11.6.1 MolMed Company Details
    • 11.6.2 MolMed Business Overview
    • 11.6.3 MolMed Stem Cells Introduction
    • 11.6.4 MolMed Revenue in Stem Cells Business (2017-2022)
    • 11.6.5 MolMed Recent Developments
  • 11.7 Pharmicell
    • 11.7.1 Pharmicell Company Details
    • 11.7.2 Pharmicell Business Overview
    • 11.7.3 Pharmicell Stem Cells Introduction
    • 11.7.4 Pharmicell Revenue in Stem Cells Business (2017-2022)
    • 11.7.5 Pharmicell Recent Developments
  • 11.8 Anterogen
    • 11.8.1 Anterogen Company Details
    • 11.8.2 Anterogen Business Overview
    • 11.8.3 Anterogen Stem Cells Introduction
    • 11.8.4 Anterogen Revenue in Stem Cells Business (2017-2022)
    • 11.8.5 Anterogen Recent Developments
  • 11.9 Takeda (TiGenix)
    • 11.9.1 Takeda (TiGenix) Company Details
    • 11.9.2 Takeda (TiGenix) Business Overview
    • 11.9.3 Takeda (TiGenix) Stem Cells Introduction
    • 11.9.4 Takeda (TiGenix) Revenue in Stem Cells Business (2017-2022)
    • 11.9.5 Takeda (TiGenix) Recent Developments
  • 11.10 CBR
    • 11.10.1 CBR Company Details
    • 11.10.2 CBR Business Overview
    • 11.10.3 CBR Stem Cells Introduction
    • 11.10.4 CBR Revenue in Stem Cells Business (2017-2022)
    • 11.10.5 CBR Recent Developments
  • 11.11 ViaCord
    • 11.11.1 ViaCord Company Details
    • 11.11.2 ViaCord Business Overview
    • 11.11.3 ViaCord Stem Cells Introduction
    • 11.11.4 ViaCord Revenue in Stem Cells Business (2017-2022)
    • 11.11.5 ViaCord Recent Developments
  • 11.12 Esperite
    • 11.12.1 Esperite Company Details
    • 11.12.2 Esperite Business Overview
    • 11.12.3 Esperite Stem Cells Introduction
    • 11.12.4 Esperite Revenue in Stem Cells Business (2017-2022)
    • 11.12.5 Esperite Recent Developments
  • 11.13 LifeCell
    • 11.13.1 LifeCell Company Details
    • 11.13.2 LifeCell Business Overview
    • 11.13.3 LifeCell Stem Cells Introduction
    • 11.13.4 LifeCell Revenue in Stem Cells Business (2017-2022)
    • 11.13.5 LifeCell Recent Developments
  • 11.14 CCBC
    • 11.14.1 CCBC Company Details
    • 11.14.2 CCBC Business Overview
    • 11.14.3 CCBC Stem Cells Introduction
    • 11.14.4 CCBC Revenue in Stem Cells Business (2017-2022)
    • 11.14.5 CCBC Recent Developments
  • 11.15 VCANBIO
    • 11.15.1 VCANBIO Company Details
    • 11.15.2 VCANBIO Business Overview
    • 11.15.3 VCANBIO Stem Cells Introduction
    • 11.15.4 VCANBIO Revenue in Stem Cells Business (2017-2022)
    • 11.15.5 VCANBIO Recent Developments
  • 11.16 BOYA LIFE
    • 11.16.1 BOYA LIFE Company Details
    • 11.16.2 BOYA LIFE Business Overview
    • 11.16.3 BOYA LIFE Stem Cells Introduction
    • 11.16.4 BOYA LIFE Revenue in Stem Cells Business (2017-2022)
    • 11.16.5 BOYA LIFE Recent Developments
  • 11.17 Beike Biotechnology
    • 11.17.1 Beike Biotechnology Company Details
    • 11.17.2 Beike Biotechnology Business Overview
    • 11.17.3 Beike Biotechnology Stem Cells Introduction
    • 11.17.4 Beike Biotechnology Revenue in Stem Cells Business (2017-2022)
    • 11.17.5 Beike Biotechnology Recent Developments
  • 11.18 International Medical
    • 11.18.1 International Medical Company Details
    • 11.18.2 International Medical Business Overview
    • 11.18.3 International Medical Stem Cells Introduction
    • 11.18.4 International Medical Revenue in Stem Cells Business (2017-2022)
    • 11.18.5 International Medical Recent Developments
  • 11.19 Global Cord Blood Corporation
    • 11.19.1 Global Cord Blood Corporation Company Details
    • 11.19.2 Global Cord Blood Corporation Business Overview
    • 11.19.3 Global Cord Blood Corporation Stem Cells Introduction
    • 11.19.4 Global Cord Blood Corporation Revenue in Stem Cells Business (2017-2022)
    • 11.19.5 Global Cord Blood Corporation Recent Developments
  • 11.20 Beijing Health-Biotech Group
    • 11.20.1 Beijing Health-Biotech Group Company Details
    • 11.20.2 Beijing Health-Biotech Group Business Overview
    • 11.20.3 Beijing Health-Biotech Group Stem Cells Introduction
    • 11.20.4 Beijing Health-Biotech Group Revenue in Stem Cells Business (2017-2022)
    • 11.20.5 Beijing Health-Biotech Group Recent Developments
  • 11.21 ABMD
    • 11.21.1 ABMD Company Details
    • 11.21.2 ABMD Business Overview
    • 11.21.3 ABMD Stem Cells Introduction
    • 11.21.4 ABMD Revenue in Stem Cells Business (2017-2022)
    • 11.21.5 ABMD Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer